Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US10537584B2 · kind B2 · utility
1Cited by
52References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2016 |
| Grant date | Jan 21, 2020 |
| Priority date | — |
| Expiry date | Jun 8, 2036 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB29L2031/753
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.